EpiAxis is pioneering next-generation LSD1 inhibitors to unlock powerful, durable treatments for patients with aggressive solid tumours, transforming resistance into responsiveness, and science into hope.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
